Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-05-18 | Thierry HoangInsider | -400,00 | 46,08k | Verkauf | 115,19 | 13,91k | -2,80% |
| 2026-05-04 | Thierry HoangInsider | -439,00 | 50,11k | Verkauf | 114,15 | 14,31k | -2,98% |
| 2026-04-30 | Mr. Steve MorrisPresident of Color Group | -200,00 | 22,92k | Verkauf | 114,58 | 7,94k | -2,46% |
| 2026-04-30 | Freemont Capital Pte. Ltd.Unternehmen | -2,13M | 233,37M | Verkauf | 109,69 | 4,18M | -33,74% |
| 2026-04-23 | Dr. Donald W. LandryIndependent Director & Member of Scientific Advisory Committee | -674,00 | 66,88k | Sale to Issuer | 99,23 | 10,45k | -6,06% |
| 2026-04-23 | Mr. Brett W. BruggemanIndependent Director & Member of Scientific Advisory Committee | -283,00 | 28,08k | Sale to Issuer | 99,23 | 3,57k | -7,35% |
| 2026-04-23 | Dr. Mario G. FerruzziIndependent Director & Chairman of Scientific Advisory Committee | -674,00 | 66,88k | Sale to Issuer | 99,23 | 8,75k | -7,15% |
| 2026-04-23 | Ms. Carol R. JacksonIndependent Director & Member of Scientific Advisory Committee | -674,00 | 66,88k | Sale to Issuer | 99,23 | 6,54k | -9,34% |
| 2026-04-23 | Mr. Scott C. MorrisonIndependent Director & Member of Scientific Advisory Committee | -674,00 | 66,88k | Sale to Issuer | 99,23 | 11,55k | -5,52% |
| 2026-04-23 | Ms. Essie Mae WhitelawDirector & Member of Scientific Advisory Committee | -674,00 | 66,88k | Sale to Issuer | 99,23 | 17,58k | -3,69% |
| 2026-03-02 | Mr. Steve MorrisPresident of Color Group | -373,00 | 37,52k | Sale to Issuer | 100,58 | 8,09k | -4,41% |
| 2026-03-02 | Mr. Adam VanderleestVP, Controller & CAO | -133,00 | 13,38k | Sale to Issuer | 100,58 | 2,41k | -5,24% |
| 2026-02-12 | Mr. Michael C. GeraghtyMember of Scientific Advisory Committee | 2,46k | 0,00 | Derivative Exercise and Retained Stock | - | 46,35k | 5,61% |
| 2026-02-12 | Mr. Michael C. GeraghtyMember of Scientific Advisory Committee | -2,46k | 241,10k | Derivative Exercise and Sale | 97,93 | 46,35k | - |
| 2026-02-12 | Thierry HoangInsider | 1,29k | 0,00 | Derivative Exercise and Retained Stock | - | 14,75k | 9,61% |
| 2026-02-12 | Ms. Amy Schmidt JonesVP of HR & Senior Counsel | 1,69k | 0,00 | Derivative Exercise and Retained Stock | - | 25,98k | 6,98% |
| 2026-02-12 | Ms. Amy Schmidt JonesVP of HR & Senior Counsel | -1,69k | 165,89k | Derivative Exercise and Sale | 97,93 | 25,98k | - |
| 2026-02-12 | Mr. John J. ManningSenior VP, General Counsel & Secretary | 2,01k | 0,00 | Derivative Exercise and Retained Stock | - | 36,32k | 5,85% |
| 2026-02-12 | Mr. John J. ManningSenior VP, General Counsel & Secretary | -2,01k | 196,64k | Derivative Exercise and Sale | 97,93 | 36,32k | - |
| 2026-02-12 | Mr. Paul ManningChairman, CEO, President & Member of Scientific Advisory Committee | 15,01k | 0,00 | Derivative Exercise and Retained Stock | - | 280,15k | 5,66% |
| 2026-02-12 | Mr. Paul ManningChairman, CEO, President & Member of Scientific Advisory Committee | -15,01k | 1,47M | Derivative Exercise and Sale | 97,93 | 280,15k | - |
| 2026-02-12 | Mr. Tobin TornehlVP & CFO | 751,00 | 0,00 | Derivative Exercise and Retained Stock | - | 16,46k | 4,78% |
| 2026-02-12 | Mr. Tobin TornehlVP & CFO | -751,00 | 73,55k | Derivative Exercise and Sale | 97,93 | 16,46k | - |
| 2025-12-08 | Mr. Tobin TornehlVP & CFO | -586,00 | 52,75k | Sale to Issuer | 90,02 | 12,81k | -4,38% |
| 2025-12-08 | Mr. Paul ManningChairman, CEO, President & Member of Scientific Advisory Committee | -11,72k | 1,06M | Sale to Issuer | 90,02 | 245,44k | -4,56% |
| 2025-12-08 | Mr. John J. ManningSenior VP, General Counsel & Secretary | -1,57k | 141,06k | Sale to Issuer | 90,02 | 31,51k | -4,74% |
| 2025-12-08 | Ms. Amy Schmidt JonesVP of HR & Senior Counsel | -1,32k | 119,01k | Sale to Issuer | 90,02 | 22,00k | -5,67% |
| 2025-12-08 | Mr. Michael C. GeraghtyMember of Scientific Advisory Committee | -1,92k | 172,93k | Sale to Issuer | 90,02 | 40,46k | -4,53% |
| 2025-11-20 | Ms. Essie Mae WhitelawDirector & Member of Scientific Advisory Committee | -4,52k | 428,38k | Verkauf | 93,22 - 95,02 | 17,13k | -20,87% |
| 2025-11-04 | Mr. David J. PlautzVP of Investor Relations & Treasurer | 2,15k | 199,91k | Kauf | 92,98 | 3,22k | 200,37% |
| 2025-11-03 | Dr. Joseph CarleoneIndependent Lead Director & Member of Scientific Advisory Committee | 1.000,00 | 91,26k | Kauf | 91,26 | 22,41k | 4,67% |
| 2025-08-11 | Mr. Paul ManningChairman, CEO, President & Member of Scientific Advisory Committee | 20,00 | 2,34k | Kauf | 116,94 | 257,15k | 0,01% |
| 2025-08-06 | Mr. Sharad P. JainIndependent Director & Member of Scientific Advisory Committee | -1,23 | 140,51 | Verkauf | 114,14 | 5,81k | -0,02% |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
